Literature DB >> 22796181

C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

Darryl D Dixon1, Marcus A Tius, Ganesh A Thakur, Han Zhou, Anna L Bowman, Vidyanand G Shukla, Yan Peng, Alexandros Makriyannis.   

Abstract

A series of tricyclic cannabinoids incorporating a heteroaroyl group at C3 were prepared as probes to explore the binding site(s) of the CB1 and CB2 receptors. This relatively unexplored structural motif is shown to be CB2 selective with K(i) values at low nanomolar concentrations when the heteroaromatic group is 3-benzothiophenyl (41) or 3-indolyl (50). When photoactivated, the lead compound 41 was shown to successfully label the CB2 receptor through covalent attachment at the active site while 50 failed to label. The benzothiophenone moiety may be a photoactivatable moiety suitable for selective labeling.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796181      PMCID: PMC3445631          DOI: 10.1016/j.bmcl.2012.06.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

Review 1.  The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Authors:  Didier M Lambert; Christopher J Fowler
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

2.  Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

Authors:  B R Martin; R Jefferson; R Winckler; J L Wiley; J W Huffman; P J Crocker; B Saha; R K Razdan
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

3.  Adamantyl cannabinoids: a novel class of cannabinergic ligands.

Authors:  Dai Lu; Zhaoxing Meng; Ganesh A Thakur; Pusheng Fan; John Steed; Cindy L Tartal; Dow P Hurst; Patricia H Reggio; Jeffrey R Deschamps; Damon A Parrish; Clifford George; Torbjörn U C Järbe; Richard J Lamb; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

4.  The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.

Authors:  A A Bremer; S E Leeman; N D Boyd
Journal:  FEBS Lett       Date:  2000-12-01       Impact factor: 4.124

Review 5.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

6.  Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.

Authors:  A A Bremer; S E Leeman; N D Boyd
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

7.  High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor.

Authors:  Chen Li; Wei Xu; Subramanian K Vadivel; Pusheng Fan; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

8.  Cannabinoid pharmacology: the first 66 years.

Authors:  Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 9.  Plant, synthetic, and endogenous cannabinoids in medicine.

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

10.  Synthesis and testing of novel phenyl substituted side-chain analogues of classical cannabinoids.

Authors:  Mathangi Krishnamurthy; Antonio M Ferreira; Bob M Moore
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

View more
  9 in total

1.  Novel adamantyl cannabinoids as CB1 receptor probes.

Authors:  Ganesh A Thakur; Shama Bajaj; Carol Paronis; Yan Peng; Anna L Bowman; Lawrence S Barak; Marc G Caron; Demon Parrish; Jeffrey R Deschamps; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2013-05-14       Impact factor: 7.446

2.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

3.  Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.

Authors:  Robert B Laprairie; Abhijit R Kulkarni; Pushkar M Kulkarni; Dow P Hurst; Diane Lynch; Patricia H Reggio; David R Janero; Roger G Pertwee; Lesley A Stevenson; Melanie E M Kelly; Eileen M Denovan-Wright; Ganesh A Thakur
Journal:  ACS Chem Neurosci       Date:  2016-04-25       Impact factor: 4.418

Review 4.  Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.

Authors:  Ian Liddle; Michelle Glass; Joel D A Tyndall; Andrea J Vernall
Journal:  RSC Med Chem       Date:  2022-04-04

5.  Synthesis and Properties of Fully-Conjugated Indacenedithiophenes.

Authors:  Brian S Young; Daniel T Chase; Jonathan L Marshall; Chris L Vonnegut; Lev N Zakharov; Michael M Haley
Journal:  Chem Sci       Date:  2014-03-01       Impact factor: 9.825

6.  Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.

Authors:  Simone Bertini; Andrea Chicca; Francesca Gado; Chiara Arena; Daniela Nieri; Maria Digiacomo; Giuseppe Saccomanni; Pingwei Zhao; Mary E Abood; Marco Macchia; Jürg Gertsch; Clementina Manera
Journal:  Bioorg Med Chem       Date:  2017-10-16       Impact factor: 3.641

7.  Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.

Authors:  Marjolein Soethoudt; Sara C Stolze; Matthias V Westphal; Luuk van Stralen; Andrea Martella; Eva J van Rooden; Wolfgang Guba; Zoltan V Varga; Hui Deng; Sander I van Kasteren; Uwe Grether; Adriaan P IJzerman; Pal Pacher; Erick M Carreira; Herman S Overkleeft; Andreea Ioan-Facsinay; Laura H Heitman; Mario van der Stelt
Journal:  J Am Chem Soc       Date:  2018-02-16       Impact factor: 15.419

Review 8.  Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes.

Authors:  Filippo Basagni; Michela Rosini; Michael Decker
Journal:  ChemMedChem       Date:  2020-06-24       Impact factor: 3.466

Review 9.  Druggable Lipid Binding Sites in Pentameric Ligand-Gated Ion Channels and Transient Receptor Potential Channels.

Authors:  Wayland W L Cheng; Mark J Arcario; John T Petroff
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.